Article

Brachytherapy software allows real-time planning

Varian BrachyTherapy, a division of Varian Medical Systems, offers anextensive line of brachytherapy products, including the GammaMed planningsoftware product line and the enhanced features of VariSeed planning softwarefor permanent brachytherapy. VariSeed's new features are designed to overcometechnical difficulties associated with the protocol, allow real-time planningin the procedure room, and enable functional image-guided therapy, accordingto the company.

Related Videos
1 expert is featured in this series.
Man talking with doctor | Image Credit: © Khunatorn - stock.adobe.com
1 expert is featured in this series.
Joshua J. Meeks, MD, PhD, gives an answer during a Zoom video interview
Related Content
Stent omission after ureteroscopy is safe, improves patient-reported outcomes
May 8th 2025

Stent omission after ureteroscopy is safe, improves patient-reported outcomes

Hannah Clarke
Patient-reported pain scores were significantly improved with stent omission.
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
May 4th 2025

Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
Physical function and frailty measures offer distinct insights in patients with bladder cancer
May 7th 2025

Physical function and frailty measures offer distinct insights in patients with bladder cancer

Hannah Clarke
Data showed that physical function and self-reported frailty assessments were poorly correlated.
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
May 1st 2025

Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025

Amy M. Pearlman, MD
Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology.
Phase 2 trial launches of (177Lu) rhPSMA-10.1 injection in mCRPC
May 6th 2025

Phase 2 trial launches of (177Lu) rhPSMA-10.1 injection in mCRPC

Hannah Clarke
Initial study results may be available as soon as the first half of 2026.
US Capitol building | Image Credit: © sherryvsmith - stock.adobe.com
May 6th 2025

AUA Advocacy Summit: Medicare payment reform among top priorities

Jennifer Miles-Thomas, MD, URPS, MBA Benjamin P. Saylor
Jennifer Miles-Thomas, MD, URPS, MBA, discusses the AUA's legislative priorities along with issues in medicine related to artificial intelligence.
© 2025 MJH Life Sciences

All rights reserved.